INSP Inspire Medical Systems, Inc.

$62.02 -1.72%

Updated 16 d ago

Healthcare · Surgical & Medical Instruments & Apparatus

Inspire Medical Systems, Inc. (INSP) is a healthcare company in the Surgical & Medical Instruments & Apparatus industry, with a market capitalization of $1.8 billion. Shares last traded at $62.02, 57.7% below their 52-week high. Over the past year the stock is down 27.6%. INSP trades at a price-to-earnings ratio of 13.28, below the Surgical & Medical Instruments & Apparatus median of 28.18. Net profit margin is 15.0%, above the peer median of -9.3%. Revenue grew 13.6% year over year.

Market Cap

$1.8B

Shares Out

28.9M

EPS (TTM)

$-0.48

P/E Ratio

13.28

P/S Ratio

1.99

P/B Ratio

2.17

Dividend / Share

—

Dividend Yield

—

52-Week High

$146.56

52-Week Low

$38.87

Volume

17,684

Avg Vol (3m)

40,303.905

Performance

+2.03%

+3.07%

+47.02%

-0.71%

YTD

-32.85%

-27.56%

Chart

Full chart →

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)

59.10

SMA (50)

$54.77

SMA (200)

$66.26

Price vs SMA50

+13.23%

Price vs SMA200

-6.41%

ATR (14)

$2.81

Full technical analysis (26 indicators, D/W/M) →

Financials

Revenue

$899M

Net Income

$135M

Gross Margin

86.1%

Operating Margin

6.0%

Net Margin

15.0%

Return on Equity

16.4%

Return on Assets

14.6%

Current Ratio

8.55

Debt / Equity

0.03

Revenue Growth (YoY)

+13.6%

Latest reported annual period ending 2026-06-30 · SEC EDGAR/XBRL.

Full financials — revenue, cash flow & debt over time →

Recent earnings

Period	EPS (diluted)	Reported
Q2 2026	$-0.38	2026-08-03
Q1 2026	$-0.39	2026-05-04
FY 2025	$4.89	2026-02-13
Q3 2025	$0.31	2025-11-03
Q2 2026	$-0.02	2026-08-03
Q1 2026	$0.10	2026-05-04

Full earnings history →

Surgical & Medical Instruments & Apparatus peers

INSP vs 14 industry peers (Surgical & Medical Instruments & Apparatus), by market cap. Updated 16 d ago

P/E vs peers

13.28 / 28.18 med

-53% discount

P/S vs peers

1.99 / 2.94 med

-32% discount

Net margin vs peers

15.0% / -9.3% med

above median

1–14 of 14


SYK	Stryker Corporation	$118.2B	31.69	4.57	14.4%	-1.31%
MMM	3M	$86.8B	28.97	3.45	11.9%	-0.28%
BSX	Boston Scientific	$68.0B	18.54	3.24	17.5%	-3.17%
BDX	Becton Dickinson	$51.1B	54.30	2.45	4.5%	+0.00%
DXCM	DexCom	$33.9B	33.86	6.81	20.1%	+0.02%
RMD	ResMed	$33.1B	21.70	5.85	26.9%	-0.78%
MDLN	Medline Inc.	$30.7B	—	1.08	—	+0.88%
WST	West Pharmaceutical Services	$24.1B	42.67	7.25	17.0%	+0.00%
SOLV	Solventum	$15.7B	10.97	1.89	17.3%	+0.56%
BAX	Baxter International	$13.2B	-12.44	1.15	-9.3%	-0.51%
PEN	Penumbra Inc	$12.7B	78.81	9.02	11.4%	-0.46%
GKOS	Glaukos Corp	$10.6B	-56.59	17.36	-30.7%	+0.52%
GMED	Globus Medical Inc	$10.5B	19.59	3.34	17.0%	-3.14%
PODD	Insulet Corporation	$10.4B	27.82	3.42	12.3%	+1.63%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.